YANTAI DONGCHENG BYANTAI DONGCHENG BYANTAI DONGCHENG B

YANTAI DONGCHENG B

No trades
See on Supercharts

002675 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Yantai Dongcheng Biochemicals Co., Ltd. engages in the research, development, production and sales of heparin sodium bulk drug and chondroitin sulfate. The company main product series include API, Preparation and Nuclide Drug Series. It manufactures active pharmaceutical ingredient, nuclear medicine, chemical synthetic drugs and modern Chinese medicines. The company’s products include heparin, chondroitin sulphate, marine collagen, hyaluronic acid, glucosamine, heparinoid and cytochrome C. Yantai Dongcheng Biochemicals was founded on December 31, 1998 and is headquartered in Yantai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

002675 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company